QLF31907
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for QLF31907, covering 2023-05-26 to 2024-05-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignant Tumors [Phase 1, Phase 2]